TIER LIST PEPTIDE EDITION

The Peptide Tier List: Greg Doucette Ranks Them All

Greg Doucette, known for his straightforward and sometimes blunt take on fitness and performance topics, puts together a tier list ranking popular peptides from S-tier (the best) down to F-tier (not worth your time). With 335,000 views, this format clearly works for the audience that wants quick, opinion-driven guidance from someone with deep experience in the bodybuilding and performance world. While tier lists are inherently subjective, Doucette backs his rankings with reasoning that draws on both the available research and his extensive experience with competitive athletes.

The tier list format is useful because it forces a direct comparison between peptides that are often discussed in isolation. When someone says BPC-157 is great, that statement means more when you know how it stacks up against TB-500, ipamorelin, and the other options available. Relative value matters when people are making decisions about what to spend their money and time on.

S-Tier: The Must-Haves

BPC-157 lands in S-tier, and this is consistent with the vast majority of practitioners and experts in the peptide space. The combination of broad tissue repair capabilities, favorable safety profile, multiple administration routes (oral and injectable), and the sheer volume of positive animal research and clinical reports puts it at the top of the list for anyone dealing with injuries or wanting general tissue support.

Doucette emphasizes that BPC-157's value is more than in treating acute injuries. It is in the cumulative tissue protection and repair that adds up over time for anyone who trains hard. Tendons, ligaments, gut lining, and joints all take damage from intense training, and BPC-157 supports the repair of all of these tissues simultaneously. For serious athletes, having this in the toolkit is close to essential.

Growth hormone secretagogues as a category also rank highly. The specific combination depends on the individual, but CJC-1295 with ipamorelin is the most commonly cited top-tier GH stack. The ability to boost natural GH production without the side effects and pituitary suppression of direct GH injection makes this combination practical for long-term use. The benefits for recovery, sleep quality, body composition, and connective tissue health are well documented in clinical practice.

A-Tier: Strong Performers

TB-500 earns A-tier status as an excellent complement to BPC-157 for tissue repair. Its cell migration and anti-inflammatory properties provide mechanisms that BPC-157 does not fully cover, which is why the two are so often stacked together. Standalone, TB-500 is still a strong peptide for injury recovery, but it gets the most value when used alongside BPC-157.

Tesamorelin ranks highly for its specific fat loss and metabolic health applications. As the only FDA-approved peptide in the GH-releasing category, it brings a level of clinical validation that most other options lack. For people focused on body composition, particularly reducing visceral fat, tesamorelin is a top choice.

Selank and semax get credit for addressing the cognitive and psychological dimensions that most peptides ignore entirely. Competitive athletes and anyone dealing with high stress loads can benefit from the anxiolytic and nootropic effects of these peptides, and the nasal administration route makes them convenient to use.

B-Tier: Solid Options

MK-677 (ibutamoren) lands in B-tier. It is an oral GH secretagogue, which is convenient since most peptides require injection. However, it comes with increased appetite and water retention that some users find unmanageable, and its longer half-life produces a less physiological GH release pattern than injectable secretagogues. It works, but it is not the cleanest option available.

DSIP (delta sleep inducing peptide) gets B-tier for its specific sleep-improving effects. It is a niche peptide that is excellent for its intended purpose but does not have the broad applicability of the higher-ranked options. For someone whose primary issue is poor sleep quality, DSIP is very useful. For someone who sleeps well already, it adds little value.

Pentadeca Arginate (PA), a newer derivative related to BPC-157, earns a mention as a potentially improved version of BPC-157 with better stability and oral bioavailability. However, it has less clinical history and research behind it, so it sits below BPC-157 until more data accumulates.

C-Tier and Below

Lower-ranked peptides include those with limited evidence, poor risk-benefit profiles, or niche applications that do more thanify their cost and complexity for most users. Doucette is direct about the fact that some popular peptides are more hype than substance, and that the peptide market has a marketing problem where every new compound is positioned as revolutionary even when the evidence is thin.

IGF-1 LR3, while powerful, ranks lower than expected because of its safety concerns (hypoglycemia risk, cancer concerns) and the need for careful medical supervision. For the average athlete or health optimizer, the risk-benefit calculation does not favor IGF-1 LR3 when safer alternatives like GH secretagogues exist. It has a place in advanced protocols for specific populations, but it is not a general recommendation.

AOD-9604, a fragment of growth hormone marketed for fat loss, also ranks lower due to inconsistent evidence. Some studies showed modest fat loss effects, but the overall body of research does not support the strong claims that marketing materials often make. The cost relative to the evidence of benefit makes it hard to recommend over better-studied alternatives.

Practical Takeaways from the Tier List

For someone new to peptides and looking to start with the highest-value options, the list simplifies to a few core recommendations. BPC-157 for tissue repair and injury management. CJC-1295 with ipamorelin for GH optimization, recovery, and body composition. TB-500 if you have significant injury issues and want to stack it with BPC-157 for enhanced repair.

Beyond those three, everything else is situational. Tesamorelin if visceral fat is a primary concern. Selank or semax if cognitive performance or anxiety is a limiting factor. DSIP if sleep quality is poor despite optimizing sleep hygiene. The rest of the peptide space has value in specific contexts but is not where most people should start.

Doucette's closing point is that no peptide replaces hard training, proper nutrition, and adequate sleep. Peptides are accelerators and optimizers, not replacements for the fundamentals. If your training is sloppy, your diet is poor, and you are sleeping five hours a night, spending money on peptides is wasteful. Fix the foundation first, then add peptides to take your results further than the foundation alone can deliver.

Building Your Personal Peptide Strategy

The tier list format is inherently simplified, and Doucette acknowledges that individual circumstances can change the ranking dramatically for any specific person. Someone with chronic gut issues might rank KPV and BPC-157 as their top priorities even though KPV is not typically in the highest tier for the general population. An athlete recovering from a major surgery might prioritize BPC-157 and TB-500 above growth hormone peptides that would otherwise rank higher in a general protocol. The tier list provides a population-level starting point, but personal needs should always modify the implementation.

Budget constraints also shape peptide strategy in practical ways. If you can only afford one peptide, BPC-157 provides the broadest utility for the widest range of concerns. If you can afford two, adding CJC-1295 with ipamorelin covers the growth hormone and recovery dimension. If you can afford three, TB-500 rounds out the tissue repair toolkit. Beyond that, the additions become increasingly specialized and less universally applicable, which means they should be driven by specific individual needs rather than a general desire to use more peptides.

Cycling and periodization also matter. Running every peptide simultaneously year-round is not necessary or advisable for most people. A more strategic approach involves using tissue repair peptides during injury recovery or heavy training blocks, GH peptides during periods focused on body composition or recovery optimization, and cognitive peptides during high-stress professional or competitive periods. This periodized approach reduces cost, prevents receptor desensitization, and allows you to assess the impact of each peptide individually rather than attributing all changes to a complex stack where the contribution of each component is impossible to isolate.

The most common mistake Doucette sees is people skipping the foundational work and jumping straight to advanced peptide stacks. He is blunt about this because it matters: if you are not training consistently with progressive overload, eating enough protein to support muscle maintenance and growth, sleeping seven to nine hours nightly, and managing your stress levels, peptides are a waste of money. They amplify the signal from good training and lifestyle habits. If that signal is weak or absent, there is nothing meaningful to amplify. Get the basics dialed in first, prove to yourself that you can sustain them for at least six months, and then consider peptides as the next layer of optimization that builds on an already solid foundation.

The peptide space will continue to evolve as new compounds are developed, existing ones are studied more rigorously, and clinical experience accumulates across thousands of practitioners and patients. Today's tier list will inevitably shift as the evidence base grows. What will not change is the principle that fundamentals come first, that peptide selection should match individual needs, and that the goal is optimization within the context of a healthy lifestyle rather than a substitute for the work that no compound can replace. That perspective, more than any specific peptide ranking, is the most valuable takeaway from this entire discussion.